Susan G. Komen FoundationNIH NCItrastuzumab deruxtecanHER2-low breast cancerThe Harvard Ludwig CenterDana-Farber Cancer InstituteHER2-lowBreast CancerHER2-0 tumors
…2-directed ADCs.Acknowledgements This work was supported by the Susan G. Komen Foundation (ASPIRE1039903, CCR18547597; FAPESP 2021/12898-8), The Harvard …